Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Blueprint Medicines Corp (BPMC)  
$102.81 0.42 (0.41%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 66,002,000
Market Cap: 6.79(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $43.96 - $108.78
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  486
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Blueprint Medicines is a precision therapy company that is inventing medicines for people with cancer and blood disorders. Co. is delivering ITS approved medicines, AYVAKIT®/AYVAKYT® (avapritinib) and GAVRETO® (pralsetinib), to patients in the U.S. and Europe, and Co. is globally developing various programs for systemic mastocytosis lung cancer and other genomically defined cancers, and cancer immunotherapy. Co.'s drug discovery approach combines its biological insights with its proprietary compound library and chemistry capabilities to design therapies, with the goal of delivering clinical benefit to patients based on the genetic driver of their disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,100
Total Buy Value $0 $0 $0 $48,378
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 145,074 190,302 263,382 381,554
Total Sell Value $13,410,702 $17,018,866 $20,928,894 $27,757,920
Total People Sold 12 12 12 12
Total Sell Transactions 23 30 39 64
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 565
  Page 11 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dorsch Marion Chief Scientific Officer   •       –      –    2021-02-22 4 OE $37.11 $281,220 D/D 7,578 22,828     -
   Hewes L. Becker Chief Medical OfficerOfficer   •       –      –    2021-01-11 3 IO $0.00 $0 D/D 0 17,500 -11%     
   Demetri George Director   –       •      –    2021-01-04 4 AS $112.15 $85,010 D/D (758) 3,562 -11%     
   Goldberg Mark Alan Director   –       •      –    2020-12-24 4 AS $125.00 $681,875 D/D (5,455) 3,562 -24%     
   Goldberg Mark Alan Director   –       •      –    2020-12-24 4 OE $28.15 $153,558 D/D 5,455 9,017     -
   Goldberg Mark Alan Director   –       •      –    2020-12-18 4 AS $120.00 $654,480 D/D (5,454) 3,562 -22%     
   Goldberg Mark Alan Director   –       •      –    2020-12-18 4 OE $28.15 $153,530 D/D 5,454 9,016     -
   Rowland Charles A Jr Director   –       •      –    2020-12-17 4 S $117.82 $1,285,298 D/D (10,909) 3,562 16%     
   Rowland Charles A Jr Director   –       •      –    2020-12-17 4 OE $19.53 $213,053 D/D 10,909 14,471     -
   Albers Jeffrey W. CEO and President   •       •      –    2020-12-14 4 AS $119.18 $595,900 D/D (5,000) 141,434 -14%     
   Albers Jeffrey W. CEO and President   •       •      –    2020-12-14 4 OE $8.80 $44,000 D/D 5,000 146,434     -
   Dorsch Marion Chief Scientific Officer   •       –      –    2020-12-14 4 AS $119.00 $547,400 D/D (4,600) 15,250 -14%     
   Dorsch Marion Chief Scientific Officer   •       –      –    2020-12-14 4 OE $37.11 $170,706 D/D 4,600 19,850     -
   Boral Anthony L. Chief Medical Officer   •       –      –    2020-12-14 4 AS $116.75 $1,185,200 D/D (10,000) 28,147 -14%     
   Boral Anthony L. Chief Medical Officer   •       –      –    2020-12-14 4 OE $15.01 $150,100 D/D 10,000 38,147     -
   Goldberg Mark Alan Director   –       •      –    2020-12-11 4 AS $115.00 $627,325 D/D (5,455) 3,562 -15%     
   Goldberg Mark Alan Director   –       •      –    2020-12-11 4 OE $28.15 $153,558 D/D 5,455 9,017     -
   Goldberg Mark Alan Director   –       •      –    2020-12-01 4 AS $110.00 $599,940 D/D (5,454) 3,562 -12%     
   Goldberg Mark Alan Director   –       •      –    2020-12-01 4 OE $28.15 $153,530 D/D 5,454 9,016     -
   Hurley Ariel Principal Accounting Officer   •       –      –    2020-12-01 4 AS $109.08 $114,053 D/D (1,038) 9,984 -12%     
   Hurley Ariel Principal Accounting Officer   •       –      –    2020-12-01 4 OE $8.80 $7,920 D/D 900 10,884     -
   Albers Jeffrey W. CEO and President   •       •      –    2020-11-16 4 AS $97.61 $1,974,295 D/D (20,000) 141,434 -7%     
   Albers Jeffrey W. CEO and President   •       •      –    2020-11-16 4 OE $8.80 $176,000 D/D 20,000 161,434     -
   Hurley Ariel Principal Accounting Officer   •       –      –    2020-11-16 4 AS $100.92 $171,564 D/D (1,700) 9,984 -7%     
   Hurley Ariel Principal Accounting Officer   •       –      –    2020-11-16 4 OE $1.87 $5,258 D/D 1,700 11,684     -
  565 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us